Hcw Biologics Inc (HCWB) Stock Price, Quote & News

Company Profile

HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and age-related diseases in the United States. The company's lead products include HCW9218, a clinical-stage bifunctional molecule, which has completed Phase 1 to treat chemotherapy-refractory solid tumor cancers and Phase 1b/2 to treat pancreatic cancer; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is i...

Industry: Biotechnology

Sector: Healthcare

Phone: 954 842 2024

Fax: 954 842 2037

Website: www.hcwbiologics.com

Address:

2929 North Commerce Parkway, Miramar, United States

ShiUnInDen Aug. 21 at 2:35 PM

$HCWB I don't kn why CEO bought

0 · Reply

Dragon3505 Aug. 20 at 4:13 PM

$HCWB under 3 dollar was a gift!! Loaded full!! Low float bio name with nice setup! Lets go bulls! Any good news and it could explode!

0 · Reply

Dragon3505 Aug. 20 at 12:01 PM

$HCWB last time when i mentioned this ticker i made 45% gain. This year this was my 3. time when i made decent gain on it. Way oversold now. Starter in. Pt 6-7

1 · Reply

Diplo Aug. 20 at 12:31 AM

$HCWB gdamnit

1 · Reply

TheUnmaker Aug. 19 at 11:02 PM

$HCWB Yeah.. Im out for now.. this is going under 3.00... maybe even 2.00

0 · Reply

RonTactical61 Aug. 19 at 10:58 PM

$HCWB total POS

0 · Reply

TheUnmaker Aug. 18 at 10:45 PM

$GRAL I always wait for that sub $32 dip and I buy more everyday. $HCWB $HSCS $BCDA

1 · Reply

Diplo Aug. 15 at 6:51 PM

$HCWB 5k shares 4.1

0 · Reply

TheUnmaker Aug. 15 at 4:08 PM

$HCWB Nice day for cheapies here.. added $BCDA $HSCS $GRAL $UNH

0 · Reply

idknowtrade Aug. 13 at 7:11 PM

$HCWB Any upcoming catalyst guys ????

0 · Reply

HCW Biologics Reports Second Quarter 2025 Business Highlights and Financial Results

Jun 27, 2025, 7:45 AM EDT - 2 months ago

HCW Biologics to Showcase Important Updates on IND-Enabling Studies and Preclinical Success of Its Novel Multi-Specific T-Cell Engagers Against Solid Tumors

Jun 26, 2025, 7:55 AM EDT - 2 months ago

HCW Biologics Regains Compliance with Nasdaq Capital Market Requirements

Jun 4, 2025, 8:20 AM EDT - 2 months ago

HCW Biologics Completes Deliverable and Solidifies License Agreement with WY Biotech

May 15, 2025, 6:14 PM EDT - 3 months ago

HCW Biologics Reports First Quarter 2025 Business Highlights and Financial Results

May 13, 2025, 8:01 PM EDT - 3 months ago

HCW Biologics Announces Pricing of $5.0 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

May 13, 2025, 8:30 AM EDT - 3 months ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Apr 1, 2025, 4:35 PM EDT - 5 months ago

HCW Biologics Announces 1-for-40 Reverse Stock Split

Mar 28, 2025, 3:30 PM EDT - 5 months ago

HCW Biologics Reports Fourth Quarter and Fiscal Year 2024 Business Highlights and Financial Results

Mar 6, 2025, 6:55 AM EST - 6 months ago

HCW Biologics Granted Extension by the Nasdaq Hearings Panel to Regain Compliance with Continued Listing Requirements

Feb 3, 2025, 7:15 AM EST - 7 months ago

HCW Biologics Granted FDA Clearance to Evaluate One of the Company's Lead Product Candidates in a First-In-Human Phase 1 Clinical Trial

Jan 15, 2025, 7:00 AM EST - 7 months ago

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

Dec 23, 2024, 8:10 AM EST - 8 months ago

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

Nov 18, 2024, 9:27 PM EST - 9 months ago

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

Nov 18, 2024, 10:15 AM EST - 9 months ago

Why Is Penny Stock HCW Biologics Surging On Monday?

Nov 18, 2024, 7:00 AM EST - 9 months ago

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

Nov 14, 2024, 4:40 PM EST - 10 months ago

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

Aug 23, 2024, 4:30 PM EDT - 1 year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights - Correction

Aug 14, 2024, 4:35 PM EDT - 1 year ago

HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights

May 15, 2024, 4:39 PM EDT - 1 year ago

HCW Biologics Reports First Quarter 2024 Financial Results and Business Highlights

Apr 1, 2024, 4:10 PM EDT - 1 year ago

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Nov 14, 2023, 7:00 AM EST - 1 year ago

HCW Biologics Reports Third Quarter 2023 Financial Results And Recent Business Highlights

Nov 8, 2023, 7:30 AM EST - 1 year ago

Investigator Sponsor of HCW Biologics' Phase 1 Clinical Trial Presented Human Data Readout and Anti-Cancer Mechanism of Action of HCW9218 at 38th SITC Annual Meeting

Nov 1, 2023, 7:30 AM EDT - 1 year ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation Human Data Readout for Phase 1 Study to Evaluate HCW9218 in Solid Tumors at SITC 38th Annual Meeting

Sep 6, 2023, 7:30 AM EDT - 2 years ago

HCW Biologics Participating at H.C. Wainwright 25th Annual Global Investment Conference in New York on September 11 – 13, 2023

Aug 11, 2023, 7:00 AM EDT - 2 years ago

HCW Biologics Reports Second Quarter 2023 Financial Results and Recent Business Highlights

Jun 14, 2023, 7:30 AM EDT - 2 years ago

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

May 9, 2023, 7:15 AM EDT - 2 years ago

HCW Biologics Reports First Quarter 2023 Financial Results And Recent Business Highlights

Apr 27, 2023, 7:40 AM EDT - 2 years ago

HCW Biologics Secures $26.25 Million Non-Dilutive Financing With Asset-Backed Development Loan

Apr 13, 2023, 7:15 AM EDT - 2 years ago

HCW Biologics Poster Presentation at AACR Annual Meeting 2023

Apr 3, 2023, 8:13 AM EDT - 2 years ago

A Novel Immunotherapeutic Approach to Treating Aging-Associated Diseases

Mar 28, 2023, 4:25 PM EDT - 2 years ago

HCW Biologics Reports Fourth Quarter and Full Year 2022 Financial Results and Recent Business Highlights

Dec 8, 2022, 7:55 AM EST - 2 years ago

HCW Biologics Enters CRADA with National Cancer Institute

Dec 7, 2022, 7:30 AM EST - 2 years ago

HCW Biologics is Granted Second Fundamental Patent: U.S. Patent for Multi-Chain Chimeric Polypeptide Created with TOBI™ Platform

Nov 8, 2022, 7:00 AM EST - 3 years ago

Masonic Cancer Center, University of Minnesota to Present Data in Poster Presentation From the Phase 1 Clinical Trial to Evaluate HCW9218 in Solid Tumors At the SITC 37th Annual Meeting

Nov 7, 2022, 4:45 PM EST - 3 years ago

HCW Biologics Reports Third Quarter 2022 Financial Results And Recent Business Highlights

Aug 31, 2022, 9:22 AM EDT - 3 years ago

HCW Biologics Inc (HCWB), Quotient Technology (QUOT) – Smith Micro Software And 3 Other Stocks Under $3 Insiders Are Aggressively Buying

SMSI

Aug 29, 2022, 8:58 AM EDT - 3 years ago

CASI Pharmaceuticals And 2 Other Stocks Under $4 Insiders Are Aggressively Buying

CASI HSDT

Aug 12, 2022, 7:00 AM EDT - 3 years ago

HCW Biologics Reports Second Quarter 2022 Financial Results And Recent Business Highlights

Aug 3, 2022, 7:15 AM EDT - 3 years ago

U.S. Patent Issued to HCW Biologics for Foundational Platform Technology

May 23, 2022, 7:30 AM EDT - 3 years ago

HCW Biologics to Participate in H.C. Wainwright Annual Global Life Sciences Conference May 23 – 25, 2022

May 13, 2022, 7:15 AM EDT - 3 years ago

HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights

May 5, 2022, 7:30 AM EDT - 3 years ago

HCW Biologics to Showcase Two Novel Groups of Fusion Molecules Created with Proprietary and Versatile TOBI™ Platform At the 105th Annual Meeting of the American Association of Immunologists

Apr 19, 2022, 7:33 AM EDT - 3 years ago

HCW Biologics' CEO Hing C. Wong, Ph.D.

Mar 28, 2022, 7:00 AM EDT - 3 years ago

HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021

Mar 24, 2022, 8:00 AM EDT - 3 years ago

HCW Biologics to Present at 2022 Virtual Growth Conference Sponsored by the Maxim Group and M-Vest

Jan 24, 2022, 9:22 AM EST - 3 years ago

Masonic Cancer Center To Evaluate HCW Biologics' Bifunctional Fusion Protein In Advanced Cancers

Jan 24, 2022, 7:00 AM EST - 3 years ago

Masonic Cancer Center at the University of Minnesota Receives FDA Clearance to Proceed with Phase 1 Clinical Trial in Solid Tumors for HCW9218, HCW Biologics' Novel Bifunctional Fusion Protein

Jan 20, 2022, 9:24 AM EST - 3 years ago

HCW Biologics Lead Candidate Shows Preclinical Anti-Tumor Activity, Reduced Side Effects of Chemo

Jan 20, 2022, 8:00 AM EST - 3 years ago

HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens

ShiUnInDen Aug. 21 at 2:35 PM

$HCWB I don't kn why CEO bought

0 · Reply

Dragon3505 Aug. 20 at 4:13 PM

$HCWB under 3 dollar was a gift!! Loaded full!! Low float bio name with nice setup! Lets go bulls! Any good news and it could explode!

0 · Reply

Dragon3505 Aug. 20 at 12:01 PM

$HCWB last time when i mentioned this ticker i made 45% gain. This year this was my 3. time when i made decent gain on it. Way oversold now. Starter in. Pt 6-7

1 · Reply

Diplo Aug. 20 at 12:31 AM

$HCWB gdamnit

1 · Reply

TheUnmaker Aug. 19 at 11:02 PM

$HCWB Yeah.. Im out for now.. this is going under 3.00... maybe even 2.00

0 · Reply

RonTactical61 Aug. 19 at 10:58 PM

$HCWB total POS

0 · Reply

TheUnmaker Aug. 18 at 10:45 PM

$GRAL I always wait for that sub $32 dip and I buy more everyday. $HCWB $HSCS $BCDA

1 · Reply

Diplo Aug. 15 at 6:51 PM

$HCWB 5k shares 4.1

0 · Reply

TheUnmaker Aug. 15 at 4:08 PM

$HCWB Nice day for cheapies here.. added $BCDA $HSCS $GRAL $UNH

0 · Reply

idknowtrade Aug. 13 at 7:11 PM

$HCWB Any upcoming catalyst guys ????

0 · Reply

TheUnmaker Aug. 13 at 4:33 PM

$GRAL Guys, take a look at $HCWB and $HSCS.. both also in the Biotech industry ready for a massive run and awaiting news.

0 · Reply

TheUnmaker Aug. 12 at 4:58 PM

$HCWB When will those end of day buy orders come in and jack the price up over $4.50+ again?

0 · Reply

oppdealer1982 Aug. 11 at 1:33 AM

$HCWB ; Hcwb have tremendous potential growth With their Amazing medical products; not to mention Brilliant Management !!!

0 · Reply

Knowledgeworthmore Aug. 10 at 12:27 PM

$HCWB HCW Biologics has completed the establishment of a GMP master cell bank for HCW9206 and has filed a drug master file with the U.S. Food and Drug Administration for its use as an ex vivo reagent. The company is currently seeking commercial partnerships for the sale of the HCW9206 reagent and its potential integration into CAR-T cell manufacturing processes.

0 · Reply

TheUnmaker Aug. 8 at 8:21 PM

$HCWB

0 · Reply

Red2Profit Aug. 5 at 5:54 PM

$HCWB Actually, neckline is at 4.44, liquiidty is at 4.53. Needs to retest 4.44 and hold. LFGOOO!

1 · Reply

Red2Profit Aug. 5 at 5:50 PM

$HCWB Watchign for a break out if it can break above 4.53 an dhold. Would be breaking a 4 hour double bottom neckline

0 · Reply

idknowtrade Aug. 4 at 8:19 PM

$HCWB

0 · Reply

TheUnmaker Aug. 4 at 7:34 PM

$PBM $HCWB Next!

0 · Reply

TheUnmaker Aug. 4 at 7:31 PM

$HCWB Whens the BOOM?

0 · Reply

JackCharvel Aug. 4 at 4:21 PM

$HCWB Anyone done real research into catalysts here?

0 · Reply

sam92 Aug. 1 at 3:44 PM

$HCWB LSEG Stocks Plus Report Latest Report 07/31/2025 LSEG maintains a current price target of $35 for HCWB

0 · Reply

Market Cap	7.43M
Revenue (ttm)	2.57M
Net Income (ttm)	-30.02M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-1,168.09%
Debt to Equity Ratio	-1.63

Volume	16,800
Avg Vol	148,872
Day's Range	N/A - N/A
Shares Out	2.15M
Stochastic %K	38%
Beta	0.66
Analysts	Strong Sell
Price Target	$35.00